Organic Active Ingredients TRIZ Cases

Intranasal androsta-4,16-dien-3-ol bypasses slow oral absorption to provide rapid anxiety relief without systemic side effects.

Targeting NUP153 overcomes drug resistance in angiogenic diseases by suppressing VEGF mRNA export without systemic toxicity.

Formula I compounds modulate TLR4 activity to reduce neuropathic pain and decrease opioid-induced tolerance.

Dissolution-enhancing agents mediate interactions between macromolecular drugs and aqueous solvents, preventing insoluble aggregate formation.

Pulsed electric field stimulation increases adenosine receptor expression on cancer cell membranes.

ATM inhibitors exploit Fanca deficiency to enhance treatment efficacy while minimizing toxicity.

Fluoro-oxindole compounds activate maxi-K channels under high calcium conditions, reversing FXS symptoms without generic neuropsychiatric treatments.

Suspended degradable microcapsules within a thermo-responsive hydrogel matrix enable extended drug release, reducing intravitreal injection frequency.

Inhaled blood serum aerosol treats respiratory disorders by delivering active compounds directly to the lungs, avoiding systemic side effects.

Targeting conserved PLpro active sites enables broad-spectrum inhibition across multiple coronavirus strains.

Incorporating pore-forming agents into semipermeable membranes eliminates laser drilling costs while ensuring consistent drug release.

Green tea catechin and citrus flavanone combinations increase tumor growth inhibition while reducing hepatotoxicity via synergistic apoptosis induction.

Sulfated chitosan derivatives mimic heparan sulfates to bind viral spike proteins, blocking SARS-CoV-2 and RSV entry while avoiding side effects.

Triphenylphosphine filtration removes oxide impurities during Sugammadex synthesis, preventing by-product formation while maintaining reaction completeness.

Combining erlotinib with 10-propargyl-10-deazaaminopterin achieves synergistic anti-tumor effects in non-small cell lung cancer treatment.

Dyrk1A inhibitors cross the blood-brain barrier to halt disease progression by reducing neurofibrillary tangles.

QTsome lipid nanoparticles protect anti-miR-21 oligonucleotides from enzymatic degradation while enabling efficient cellular uptake and endosomal release.

Single enflicoxib dosing extends analgesic duration, reducing daily administration frequency and improving owner compliance for canine surgical recovery.

Bifunctional fusion polymers bind exposed collagenous proteins to sequester chemotherapeutic agents at tumor sites.

NMR-based metabolomics detects specific joint fluid metabolites to identify Pseudomonas aeruginosa biofilms, overcoming antibiotic resistance limitations.

Tamarind seed polysaccharide gel resolves cervical ectropion relapse issues by providing durable mucoadhesion and sustained release.

Implantable pumps deliver browning agents to white adipose tissue, resolving unintended adverse consequences from systemic administration.

A biguanide derivative compound inhibits inflammatory cytokine generation while promoting regulatory T cell activity.

TMAVA antagonists prevent ectopic fatty acid accumulation in the liver and heart, addressing ineffective NAFLD treatments.

2,3-dihydrobenzohurans target BD2 domains to reduce inflammatory responses while minimizing off-target effects.

Biodegradable polymer implants release acriflavine directly at the tumor site to bypass systemic circulation barriers.

Nucleic acid aptamers suppress inflammatory cytokines via BCMA targeting, reducing side effects from long-term corticosteroid or antibody therapies.

Bicyclic pyrimidine derivatives block cancer cell proliferation and reduce phosphorylated tau protein levels by inhibiting hGGPPS activity.

A pharmaceutical composition targets DCUN1D3 protein activity to reduce cellular senescence levels in mammalian tissues.

Scutellarin meglumine salt improves water solubility via ionic bonding, preventing phenolic oxidation and eliminating complex pH buffers.

2-Pyridyl carboxamide compounds inhibit Syk kinase to treat inflammatory diseases like asthma and rheumatoid arthritis.

Effervescent pregabalin and vitamin B12 formulations dissolve rapidly in water, resolving swallowing difficulties for pediatric and geriatric patients.

Direct substrate supplementation bypasses the defective phosphoglucomutase enzyme to restart stalled glycosylation processes.

Segmented cyanopyrrolidine inhibitors target USP30 to resolve the contradiction between therapeutic efficacy and cellular toxicity in mitochondrial dysfunction.

Heat treatment of a steroid wet mass with water and excipient avoids ethylene oxide residues and thermal degradation.

Five-member-heterocycle fused pyridine compounds inhibit c-Met kinase activity through specific molecular structures.

Soluble beta-glucan enhances immunostimulatory functions within the tumor microenvironment to boost anti-cancer agent efficacy.

Administering RNA interference to inhibit PAX-6 gene expression, addressing the lack of effective treatments and risk assessments for myopia.

Hypomethylating agents treat hypertrophic cardiomyopathy by inhibiting DNA methylation, reducing hypertrophy and fibrosis while improving cardiac function.

Low-dose progesterone antagonists inhibit autocrine HCG production to prevent carcinogenesis at a low cost.

Targeting 11β-HSD1 with a triazole derivative resolves the contradiction between analgesic efficacy and side effects for neuropathic pain treatment.

A biodegradable intraocular device maintains therapeutic drug concentrations through a semipermeable membrane.